Jim Cramer Recently Looked at These 25 Stocks
We're in critical short supply for all sorts of chips that are needed in the data center... It wasn't easy to forecast this boom, I admit, as recently as one year ago.
Crinetics Pharmaceuticals Inc. (CRNX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Driehaus Capital Richard Driehaus | 6,481,613 | $269,959,181 | +2% | 1.93% |
| 2. | Farallon Capital Thomas Steyer | 5,770,098 | $240,324,582 | +25% | 0.98% |
| 3. | EcoR1 Capital Oleg Nodelman | 4,288,120 | $178,600,198 | 8.57% | |
| 4. | Point72 Asset Management Steve Cohen | 2,003,333 | $83,438,803 | +1% | 0.14% |
| 5. | Siren L.L.C. Raymond Debbane | 1,688,611 | $70,330,648 | 2.75% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.06 | 5,000 | $110,300.00 | 5,000 | 2023-06-08 | Filing | |
| $22.22 | 157,515 | $3,499,983.30 | 5,321,032 | 2022-04-18 | Filing | |
| $19.80 | 1,200,000 | $23,760,000.00 | 5,163,517 | 2021-10-25 | Filing | |
| $16.44 | 304,136 | $4,999,995.84 | 3,963,517 | 2021-04-08 | Filing | |
| $13.10 | 4,000 | $52,400.00 | 4,000 | 2020-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.00 | 2,500 | $137,500.00 | 834 | 2026-01-05 | Filing | |
| $45.02 | 5,000 | $225,100.00 | 66,837 | 2025-12-01 | Filing | |
| $43.27 | 100 | $4,327.00 | 66,270 | 2025-11-03 | Filing | |
| $42.65 | 4,900 | $208,985.00 | 66,370 | 2025-11-03 | Filing | |
| $41.81 | 5,000 | $209,050.00 | 66,270 | 2025-10-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 674,533 | $31,399,511 | 0.05% | |
| 2. | 408,312 | $19,006,923 | 0.03% | |
| 3. | 53,877 | $2,507,974 | 0.33% | |
| 4. | 26,105 | $1,215,188 | 0.49% | |
| 5. | 25,014 | $1,164,402 | 0.01% |
News See All
Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is among the 14 best booming stocks to buy right now.
14 Best Booming Stocks to Buy Right Now
In a report released on January 9, Goldman Sachs said that it expects the index to rally 12% in 2026.
Crinetics Pharmaceuticals (CRNX) Poised for Transformational Growth in 2026: Piper Sandler
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Piper Sandler reiterated that Crinetics Pharmaceuticals Inc.
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q3 2025 Earnings Call Transcript
Operator: Welcome to the Crinetics Pharmaceuticals Third Quarter 2025 Financial Results Conference Call. I would now like to turn the call over to Gayathri Diwakar, Head of Investor Relations.
Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best biotech stocks with high potential.
14 Biotech Stocks with High Potential
Healthcare was the second worst performer this year, with pharma and biotech companies under pressure.
JMP Backs Crinetics Pharmaceuticals, Inc. (CRNX) With Big Upside Post-Approval
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is among the best fast money stocks to buy now.
JPMorgan Lifts PT on Crinetics Pharmaceuticals (CRNX) to $52 From $53, Keeps an Overweight Rating
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best strong buy stocks to invest in according to Wall Street.